Middle East & Africa Medical Rubber Stopper Market Size & Outlook
Middle East & Africa medical rubber stopper market, 2018-2030 (US$M)
Related Markets
MEA medical rubber stopper market highlights
- The MEA medical rubber stopper market generated a revenue of USD 193.1 million in 2023.
- The market is expected to grow at a CAGR of 3.3% from 2024 to 2030.
- In terms of segment, teflon coated was the largest revenue generating surface treatment in 2023.
- Teflon Coated is the most lucrative surface treatment segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 193.1 million |
| Market revenue in 2030 | USD 242.5 million |
| Growth rate | 3.3% (CAGR from 2023 to 2030) |
| Largest segment | Teflon coated |
| Fastest growing segment | Teflon Coated |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Siliconized, Teflon Coated, Uncoated Stoppers |
| Key market players worldwide | AptarGroup Inc, West Pharmaceutical Services Inc, Samsung Electronics Co Ltd, Daetwyler Holding AG, Bharat Rubber Works, Jiangyin Hongmeng Rubber and Plastic Products Co., Universal Medicap, Lonstroff, Bormioli Pharma, Sagar Rubber Products |
Other key industry trends
- In terms of revenue, MEA region accounted for 10.9% of the global medical rubber stopper market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 305.9 million by 2030.
Teflon coated was the largest segment with a revenue share of 62.35% in 2023. Horizon Databook has segmented the Middle East & Africa medical rubber stopper market based on siliconized, teflon coated, uncoated stoppers covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceuticals industry in the Middle East & Africa mostly relies on pharmaceutical imports. Although local pharmaceutical manufacturers and global players have an established presence in the region, the demand and supply gap owing to the significant population increase is straining the domestic production of pharmaceuticals in the region.
The GCC countries in the Middle East have a wellestablished healthcare infrastructure as the oil-driven economy of these countries funds the development of this infrastructure. In Africa, a significant number of countries fall in the below-low-income category.
Moreover, they are politically unstable and have underdeveloped healthcare and pharmaceutical industries. Countries such as Tanzania, South Africa, Egypt, and Kenya have a more established healthcare infrastructure than some other economically weak countries in Africa. According to the U.S. Pharmacopeial Convention, only 1% of vaccines consumed in Africa are produced on the continent.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Rubber Stopper Market Scope
Medical Rubber Stopper Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA medical rubber stopper market size, by country, 2018-2030 (US$M)
Middle East & Africa Medical Rubber Stopper Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
